JP Morgan Chase’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
JP Morgan Chase's PYXS Position: Q3 2026 in Review
JP Morgan Chase increased its Pyxis Oncology (PYXS) stake by 18% in Q3 2026, buying an estimated $3K and bringing the position to 6,537 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #6932.
JP Morgan Chase first reported a position in PYXS in Q4 2021 and has held it in 17 quarters since. The position peaked at $129K in Q4 2021. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- JP Morgan Chase held 6,537 shares of Pyxis Oncology worth $19K as of Q3 2026.
- JP Morgan Chase bought 992 Pyxis Oncology shares in Q3 2026, an estimated $3K.
- Pyxis Oncology made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6932 holding.
- JP Morgan Chase first reported a position in Pyxis Oncology in Q4 2021 and has held it in 17 quarters since.
- JP Morgan Chase's Pyxis Oncology position peaked at $129K in Q4 2021.
- 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.